Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
SGX203
print preview
bookmark
share with colleague
General Information
Company
Soligenix Inc.
Description
Oral beclomethasone 17,21-dipropionate (BDP)
Molecular Target
Corticoid receptors
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Crohn's disease
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy